Home > Insider Trading > Filing (0001055726-21-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1055726	Inovio Pharmaceuticals Inc.	INO	Surgical & Medical Instruments & Apparatus (3841)	330969592

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1259780	Peter Kies	C/O Inovio Pharmaceuticals, Inc. 6769 Mesa Ridge Road San Diego CA 92121	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-15	30,000	$4.56	149,290	No	4	M	Direct
Common Stock	Disposition	2021-01-15	30,000	$10.02	119,290	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option	Disposition	2021-01-15	30,000	$0.00	30,000	$4.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-03-11	2021-03-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,500	Indirect	By Spouse

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
These transactions were executed in multiple trades at prices ranging from $10.00 to $10.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.